Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes

Published:2020-03 Issue: Volume:125 Page:170203
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Irwin Nigel^ORCID,Gault Victor A.^ORCID,O’Harte Finbarr P.M.^ORCID,Flatt Peter R.

Funder

Diabetes UK

European Foundation for the Study of Diabetes

Invest Northern Ireland

Irish Endocrine Society

SAAD Trading and Contracting Company

Department for the Economy (DfE) Northern Ireland

Diabetes Research & Wellness Foundation

University of Ulster strategic research funding

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference119 articles.

1. Global Report on Obesity;World Health Organisation,2018

2. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetologia,2018

3. Obesity: pathophysiology and management;Gadde;J. Am. Coll. Cardiol.,2018

4. Enteroendocrine hormone mimetics for the treatment of obesity and diabetes;Irwin;Curr. Opin. Pharmacol.,2013

5. New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders;Irwin;World J. Diabetes,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance;International Journal of Molecular Sciences;2024-08-08

2. Chronic exposure to incretin metabolites GLP-1(9−36) and GIP(3−42) affect islet morphology and beta cell health in high fat fed mice;Peptides;2024-08

3. Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?;Journal of Endocrinology;2024-06-11

4. Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus;Exploration of Drug Science;2024-04-03

5. Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes;Peptides;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3